Parkinson’s Disease Meets Immunology | Azathioprine Trial Explained
Автор: GEETA IAS / PSC / SSC
Загружено: 2025-12-17
Просмотров: 25
Full study link—https://www.thelancet.com/journals/la...
A new Lancet Neurology phase-2 clinical trial tested azathioprine, an immunosuppressing drug, in people with early Parkinson’s disease—not to treat symptoms, but to see if it could slow disease progression.
Parkinson’s has long been viewed as a dopamine disorder, but growing evidence shows the immune system and inflammation may play a key role.
This randomized, double-blind, placebo-controlled trial from the UK explored a bold idea:
👉 Can calming the immune system protect the brain?
In this video, we explain:
What Parkinson’s disease really is (in simple terms)
Why scientists targeted the immune system
What Azathioprine does in the body
What the trial found—and what it did NOT prove
Why this research matters for future Parkinson’s treatment
⚠️ This is not medical advice—this video explains science, evidence, and unanswered questions.
📚 Source: The Lancet Neurology
🎯 For students, journalists, doctors, caregivers & science-curious minds.
👉 Like, share & subscribe for evidence-based neuroscience and health journalism.
#ParkinsonsDisease
#Neuroscience
#MedicalResearch
#LancetNeurology
#BrainHealth
#Neuroinflammation
#ScienceExplained
#HealthJournalism
#ParkinsonsResearch
#ClinicalTrials
#2025
#2026
#2027
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
![Биология поведения человека. Лекция #1. Введение [Роберт Сапольски, 2010. Стэнфорд]](https://ricktube.ru/thumbnail/ik9t96SMtB0/mqdefault.jpg)
